Quintiles sheds CRO label

Apparently, it's becoming unfashionable to be labeled a CRO. Pack-leader Quintiles is now a "biopharmaceutical services company," says EVP Ron Wooten. Though the group will still do outsourced clinical trial work, Quintiles wanted a title that better captured its other activities, which include investing in drug development and marketing newly-approved drugs. And pharmacovigilance company Drug Safety Alliance has tried to shed the CRO label in favor of the more apt "drug safety company." It may be a local phenomenon, though; both identity-enhancing companies are based in Durham, NC. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.